Las pruebas de aliento con isótopos marcados con carbono 13: una nueva herramienta de diagnóstico, costo-eficiente y con seguridad para el paciente

  • Germán Campuzano-Maya Laboratorio Clínico Hematológico

Descargas

La descarga de datos todavía no está disponible.

Biografía del autor/a

Germán Campuzano-Maya, Laboratorio Clínico Hematológico

Director-Editor, Medicina & Laboratorio. Medellín, Colombia.

Referencias bibliográficas

Dodds C. Variations in alveolar carbon dioxide pressure in relation to meals. J Physiol (London) 1920;54:342-348.

https://doi.org/10.1113/jphysiol.1921.sp001935

Komberg HL, Davis RE. Gastric urease. Physiol Rev 1955;35:169-177.

https://doi.org/10.1152/physrev.1955.35.1.169

Kerlin P, Wong L, Harris B, Capra S. Rice flour, breath hydrogen, and malabsorption. Gastroenterology 1984;87:578-585.

https://doi.org/10.1016/0016-5085(84)90529-8

Graham DY, Klein PD, Evans DJ, Jr., Evans DG, Alpert LC, Opekun AR, et al. Campylobacter pylori detected noninvasively by the 13C-urea breath test. Lancet 1987;1:1174-1177.

https://doi.org/10.1016/S0140-6736(87)92145-3

Warren J, Marshall B. Unidentified curved baccilli on gastric epithelium in active chronic gastritis. Lancet 1983;1273-1275.

https://doi.org/10.1016/S0140-6736(83)92719-8

Gisbert JP, Pajares JM. Review article: 13C-urea breath test in the diagnosis of Helicobacter pylori infection -- a critical review. Aliment Pharmacol Ther 2004;20:1001-1017.

https://doi.org/10.1111/j.1365-2036.2004.02203.x

Campuzano-Maya G. An optimized 13C-urea breath test for the diagnosis of H pylori infection. World J Gastroenterol 2007;13:5454-5464.

https://doi.org/10.3748/wjg.v13.i41.5454

Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, et al. Management of Helicobacter pylori infection--the Maastricht IV/Florence Consensus Report. Gut 2012;61:646-664.

https://doi.org/10.1136/gutjnl-2012-302084

Hiele M, Ghoos Y, Rutgeerts P, Vantrappen G. Starch digestion in normal subjects and patients with pancreatic disease, using a 13CO2 breath test. Gastroenterology 1989;96:503-509.

https://doi.org/10.1016/0016-5085(89)91577-1

Herzog DC, Delvin EE, Albert C, Marcotte JE, Pelletier VA, Seidman EG. 13C-labeled mixed triglyceride breath test (13C MTG-BT) in healthy children and children with cystic fibrosis (CF) under pancreatic enzyme replacement therapy (PERT): a pilot study. Clin Biochem 2008;41:1489-1492.

https://doi.org/10.1016/j.clinbiochem.2008.08.087

Nakamura H, Morifuji M, Murakami Y, Uemura K, Ohge H, Hayashidani Y, et al. Usefulness of a 13C-labeled mixed triglyceride breath test for assessing pancreatic exocrine function after pancreatic surgery. Surgery 2009;145:168-175.

https://doi.org/10.1016/j.surg.2008.08.013

Hirono S, Murakami Y, Tani M, Kawai M, Okada K, Uemura K, et al. Identification of risk factors for pancreatic exocrine insufficiency after pancreaticoduodenectomy using a 13C-labeled mixed triglyceride breath test. World J Surg 2015;39:516-525.

https://doi.org/10.1007/s00268-014-2832-4

Ghoos YF, Maes BD, Geypens BJ, Mys G, Hiele MI, Rutgeerts PJ, et al. Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology 1993;104:1640-1647.

https://doi.org/10.1016/0016-5085(93)90640-X

Hauser B, De Schepper J, Caveliers V, Salvatore S, Salvatoni A, Vandenplas Y. Variability of the 13C-acetate breath test for gastric emptying of liquids in healthy children. J Pediatr Gastroenterol Nutr 2006;42:392-397.

https://doi.org/10.1097/01.mpg.0000215306.40546.17

Hauser B, De Schepper J, Caveliers V, Salvatore S, Salvatoni A, Vandenplas Y. Variability of the 13C-octanoic acid breath test for gastric emptying of solids in healthy children. Aliment Pharmacol Ther 2006;23:1315-1319.

https://doi.org/10.1111/j.1365-2036.2006.02892.x

Wutzke KD, Heine WE, Plath C, Leitzmann P, Radke M, Mohr C, et al. Evaluation of oro-coecal transit time: a comparison of the lactose-[13C, 15N]ureide 13CO2- and the lactulose H2-breath test in humans. Eur J Clin Nutr 1997;51:11-19.

https://doi.org/10.1038/sj.ejcn.1600353

Dellert SF, Nowicki MJ, Farrell MK, Delente J, Heubi JE. The 13C-xylose breath test for the diagnosis of small bowel bacterial overgrowth in children. J Pediatr Gastroenterol Nutr 1997;25:153-158.

https://doi.org/10.1097/00005176-199708000-00005

Hiele M, Ghoos Y, Rutgeerts P, Vantrappen G, Carchon H, Eggermont E. 13CO2 breath test using naturally 13C-enriched lactose for detection of lactase deficiency in patients with gastrointestinal symptoms. J Lab Clin Med 1988;112:193-200.

Koetse HA, Stellaard F, Bijleveld CM, Elzinga H, Boverhof R, van der Meer R, et al. Non-invasive detection of low-intestinal lactase activity in children by use of a combined 13CO2/H2 breath test. Scand J Gastroenterol 1999;34:35-40.

https://doi.org/10.1080/00365529950172808

Vonk RJ, Stellaard F, Priebe MG, Koetse HA, Hagedoorn RE, De Bruijn S, et al. The 13C/2H-glucose test for determination of small intestinal lactase activity. Eur J Clin Invest 2001;31:226-233.

https://doi.org/10.1046/j.1365-2362.2001.00791.x

Ritchie BK, Brewster DR, Davidson GP, Tran CD, McNeil Y, Hawkes JS, et al. 13C-sucrose breath test: novel use of a noninvasive biomarker of environmental gut health. Pediatrics 2009;124:620-626.

https://doi.org/10.1542/peds.2008-2257

Gudmand-Hoyer E. Sucrose malabsorption in children: a report of thirty-one Greenlanders. J Pediatr Gastroenterol Nutr 1985;4:873-877.

https://doi.org/10.1097/00005176-198512000-00005

Dillon EL, Janghorbani M, Angel JA, Casperson SL, Grady JJ, Urban RJ, et al. Novel noninvasive breath test method for screening individuals at risk for diabetes. Diabetes Care 2009;32:430-435.

https://doi.org/10.2337/dc08-1578

Lewanczuk RZ, Paty BW, Toth EL. Comparison of the 13C-glucose breath test to the hyperinsulinemic-euglycemic clamp when determining insulin resistance. Diabetes Care 2004;27:441-447.

https://doi.org/10.2337/diacare.27.2.441

Mizrahi M, Lalazar G, Adar T, Raz I, Ilan Y. Assessment of insulin resistance by a 13C-glucose breath test: a new tool for early diagnosis and follow-up of high-risk patients. Nutr J 2010;9:25.

https://doi.org/10.1186/1475-2891-9-25

Klein PD. 13C breath tests: visions and realities. J Nutr 2001;131:1637S-1642S.

https://doi.org/10.1093/jn/131.5.1637S

Ghoos Y, Geypens B, Rutgeerts P. Stable isotopes and 13CO2 breath tests for investigating gastrointestinal functions. Food Nutr Bull 2002;23:166-168.

https://doi.org/10.1177/15648265020233S132

Cao W, Duan Y. Breath analysis: potential for clinical diagnosis and exposure assessment. Clinical chemistry 2006;52:800-811.

https://doi.org/10.1373/clinchem.2005.063545

Jassal MS, Nedeltchev GG, Lee JH, Choi SW, Atudorei V, Sharp ZD, et al. 13C-urea breath test as a novel point-of-care biomarker for tuberculosis treatment and diagnosis. PLoS One 2010;5:e12451.

https://doi.org/10.1371/journal.pone.0012451

Maiga M, Abaza A, Bishai WR. Current tuberculosis diagnostic tools & role of urease breath test. Indian J Med Res 2012;135:731-736.

Beste DJ, Noh K, Niedenfuhr S, Mendum TA, Hawkins ND, Ward JL, et al. 13C-flux spectral analysis of host-pathogen metabolism reveals a mixed diet for intracellular Mycobacterium tuberculosis. Chem Biol 2013;20:1012-1021.

https://doi.org/10.1016/j.chembiol.2013.06.012

Clemens DL, Lee BY, Horwitz MA. Purification, characterization, and genetic analysis of Mycobacterium tuberculosis urease, a potentially critical determinant of host-pathogen interaction. J Bacteriol 1995;177:5644-5652.

https://doi.org/10.1128/JB.177.19.5644-5652.1995

Lin W, Mathys V, Ang EL, Koh VH, Martinez Gomez JM, Ang ML, et al. Urease activity represents an alternative pathway for Mycobacterium tuberculosis nitrogen metabolism. Infect Immun 2012;80:2771-2779.

https://doi.org/10.1128/IAI.06195-11

Johnson PJ. Role of the standard 'liver function tests' in current clinical practice. Ann Clin Biochem 1989;26 ( Pt 6):463-471.

https://doi.org/10.1177/000456328902600601

Shaheen AA, Wan AF, Myers RP. FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy. Am J Gastroenterol 2007;102:2589-2600.

https://doi.org/10.1111/j.1572-0241.2007.01466.x

Fernández-Daza E, Fernández JE, Moreno-Mejía I, Moreno-Mejía M. Aproximación al diagnóstico de enfermedades hepáticas por el laboratorio clínico. Medicina & Laboratorio 2008;14:533-546.

Smith JO, Sterling RK. Systematic review: non-invasive methods of fibrosis analysis in chronic hepatitis C. Alimentary pharmacology & therapeutics 2009;30:557-576.

https://doi.org/10.1111/j.1365-2036.2009.04062.x

Pais R, Lupsor M, Poanta L, Silaghi A, Rusu ML, Badea R, et al. Liver biopsy versus noninvasive methods--fibroscan and fibrotest in the diagnosis of non-alcoholic fatty liver disease: a review of the literature. Rom J Intern Med 2009;47:331-340.

Tygstrup N. Assessment of liver function: principles and practice. J Gastroenterol Hepatol 1990;5:468-482.

https://doi.org/10.1111/j.1440-1746.1990.tb01426.x

Braden B. Methods and functions: Breath tests. Best Pract Res Clin Gastroenterol 2009;23:337-352.

https://doi.org/10.1016/j.bpg.2009.02.014

Masucci L, Blackhouse G, Goeree R. Cost-effectiveness of the Carbon-13 Urea Breath Test for the Detection of Helicobacter Pylori: An Economic Analysis. Ont Health Technol Assess Ser 2013;13:1-28.

Pizzoferrato M, Del Zompo F, Mangiola F, Lopetuso LR, Petito V, Cammarota G, et al. Specific 13C functional pathways as diagnostic targets in gastroenterology breath-tests: tricks for a correct interpretation. Eur Rev Med Pharmacol Sci 2013;17 Suppl 2:45-50.

Ilan Y. Review article: the assessment of liver function using breath tests. Aliment Pharmacol Ther 2007;26:1293-1302.

https://doi.org/10.1111/j.1365-2036.2007.03519.x

Park GJ, Katelaris PH, Jones DB, Seow F, Le Couteur DG, Ngu MC. Validity of the 13C-caffeine breath test as a noninvasive, quantitative test of liver function. Hepatology 2003;38:1227-1236.

https://doi.org/10.1053/jhep.2003.50475

Park GJ, Katelaris PH, Jones DB, Seow F, Lin BP, Le Couteur DG, et al. The C-caffeine breath test distinguishes significant fibrosis in chronic hepatitis B and reflects response to lamivudine therapy. Aliment Pharmacol Ther 2005;22:395-403.

https://doi.org/10.1111/j.1365-2036.2005.02623.x

Zhang GS, Bao ZJ, Zou J, Yin SM, Huang YQ, Huang H, et al. Clinical research on liver reserve function by 13C-phenylalanine breath test in aged patients with chronic liver diseases. BMC Geriatr 2010;10:23.

https://doi.org/10.1186/1471-2318-10-23

Mion F, Rousseau M, Scoazec JY, Berger F, Minaire Y. 13C-galactose breath test: correlation with liver fibrosis in chronic hepatitis C. Eur J Clin Invest 1999;29:624-629.

https://doi.org/10.1046/j.1365-2362.1999.00512.x

Giannini E, Fasoli A, Chiarbonello B, Malfatti F, Romagnoli P, Botta F, et al. 13C-aminopyrine breath test to evaluate severity of disease in patients with chronic hepatitis C virus infection. Aliment Pharmacol Ther 2002;16:717-725.

https://doi.org/10.1046/j.1365-2036.2002.01200.x

Braden B, Faust D, Sarrazin U, Zeuzem S, Dietrich CF, Caspary WF, et al. 13C-methacetin breath test as liver function test in patients with chronic hepatitis C virus infection. Aliment Pharmacol Ther 2005;21:179-185.

https://doi.org/10.1111/j.1365-2036.2005.02317.x

Schneider AR, Teuber G, Paul K, Nikodem A, Duesterhoeft M, Caspary WF, et al. Patient age is a strong independent predictor of 13C-aminopyrine breath test results: a comparative study with histology, duplex-Doppler and a laboratory index in patients with chronic hepatitis C virus infection. Clin Exp Pharmacol Physiol 2006;33:300-304.

https://doi.org/10.1111/j.1440-1681.2006.04365.x

Goetze O, Selzner N, Fruehauf H, Fried M, Gerlach T, Mullhaupt B. 13C-methacetin breath test as a quantitative liver function test in patients with chronic hepatitis C infection: continuous automatic molecular correlation spectroscopy compared to isotopic ratio mass spectrometry. Aliment Pharmacol Ther 2007;26:305-311.

https://doi.org/10.1111/j.1365-2036.2007.03360.x

Dinesen L, Caspary WF, Chapman RW, Dietrich CF, Sarrazin C, Braden B. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C. Dig Liver Dis 2008;40:743-748.

https://doi.org/10.1016/j.dld.2008.01.013

Rocco A, de Nucci G, Valente G, Compare D, D'Arienzo A, Cimino L, et al. 13C-aminopyrine breath test accurately predicts long-term outcome of chronic hepatitis C. J Hepatol 2012;56:782-787.

https://doi.org/10.1016/j.jhep.2011.10.015

Fierbinteanu-Braticevici C, Papacocea R, Tribus L, Cristian B. The role of 13C-methacetin breath test for non invasive staging of liver fibrosis in patients with chronic hepatitis C. Indian J Med Res 2014;140:123-129.

https://doi.org/10.1016/S0016-5085(11)62908-9

Spahr L, Negro F, Leandro G, Marinescu O, Goodman KJ, Rubbia-Brandt L, et al. Impaired hepatic mitochondrial oxidation using the 13C-methionine breath test in patients with macrovesicular steatosis and patients with cirrhosis. Med Sci Monit 2003;9:CR6-11.

Miele L, Grieco A, Armuzzi A, Candelli M, Forgione A, Gasbarrini A, et al. Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test. Am J Gastroenterol 2003;98:2335-2336.

https://doi.org/10.1111/j.1572-0241.2003.07725.x

Schmilovitz-Weiss H, Niv Y, Pappo O, Halpern M, Sulkes J, Braun M, et al. The 13C-caffeine breath test detects significant fibrosis in patients with nonalcoholic steatohepatitis. J Clin Gastroenterol 2008;42:408-412.

https://doi.org/10.1097/MCG.0b013e318046ea65

Mawatari H, Inamori M, Fujita K, Yoneda M, Iida H, Endo H, et al. The continuous real-time 13C-octanoate breath test for patients with nonalcoholic steatohepatitis using the BreathID system. Hepatogastroenterology 2009;56:1436-1438.

Duro D, Fitzgibbons S, Valim C, Yang CF, Zurakowski D, Dolan M, et al. 13C-Methionine breath test to assess intestinal failure-associated liver disease. Pediatr Res 2010;68:349-354.

https://doi.org/10.1203/PDR.0b013e3181ed15e5

Shteyer E, Lalazar G, Hemed N, Pappo O, Granot E, Yerushalmi B, et al. Continuous 13C-methacetin breath test differentiates biliary atresia from other causes of neonatal cholestasis. J Pediatr Gastroenterol Nutr 2013;56:60-65.

https://doi.org/10.1097/MPG.0b013e3182638d29

Petrolati A, Festi D, De Berardinis G, Colaiocco-Ferrante L, Di Paolo D, Tisone G, et al. 13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation. Aliment Pharmacol Ther 2003;18:785-790.

https://doi.org/10.1046/j.1365-2036.2003.01752.x

Ishii Y, Asai S, Kohno T, Takahashi Y, Nagata T, Suzuki S, et al. Evaluation of liver regeneration using the L-1-13C-methionine breath test. J Surg Res 2001;95:195-199.

https://doi.org/10.1006/jsre.2000.6012

Ishii Y, Asai S, Kohno T, Ito A, Iwai S, Ishikawa K. Recovery of liver function in two-third partial hepatectomized rats evaluated by L-1-13C-phenylalanine breath test. Surgery 2002;132:849-856.

https://doi.org/10.1067/msy.2002.127947

Eisenberg JM. The Agency for Healthcare Research and Quality: new challenges, new opportunities. Health services research 2000;35:xi-xvi.

Plebani M, Lippi G. Improving diagnosis and reducing diagnostic errors: the next frontier of laboratory medicine. Clin Chem Lab Med 2016.

https://doi.org/10.1515/cclm-2016-0217

Lippi G, Plebani M. Improving accuracy of diagnostic studies in a world with limited resources: a road ahead. Ann Transl Med 2016;4:43.

Cómo citar
1.
Campuzano-Maya G. Las pruebas de aliento con isótopos marcados con carbono 13: una nueva herramienta de diagnóstico, costo-eficiente y con seguridad para el paciente. Med. Lab. [Internet]. 1 de septiembre de 2015 [citado 29 de noviembre de 2020];21(9-10):409-12. Disponible en: https://medicinaylaboratorio.com/index.php/myl/article/view/137
Publicado
2015-09-01
Sección
Editorial